Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
Abroad (travel likely)RecruitingPHASE3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Metastatic Breast Cancer
Locations
- Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
- Public Health Institute of Sun Yat-sen University, Guangzhou, Guangdong, China
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
- The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
- Shantou Central Hospital, Shantou, Guangdong, China
- Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen, Guangdong, China
- Shenzhen People's Hospital, Shenzhen, Guangdong, China
- Affiliated Hospital of Guangdong Medical University, Zhangjiang, Guangdong, China
- Fifth Subsidiary Sun Yat-sen University Hospital, Zhuhai, Guangdong, China
- Affiliated Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China
- Hunan Cancer Hospital, Changsha, Hunan, China